We are live on ! Find out more
WE

Wealth Effects Portfolio holdings

AUM $282M
1-Year Est. Return 62.81%
This Fund
S&P 500
This Quarter Est. Return
+23.73%
1 Year Est. Return
+62.81%
3 Year Est. Return
+160.11%
5 Year Est. Return
10 Year Est. Return
AUM
$227M
AUM Growth
+$31.9M
Cap. Flow
-$1.77M
Cap. Flow %
-0.78%
Top 10 Hldgs %
46.5%
Holding
213
New
15
Increased
72
Reduced
78
Closed
11

Sector Composition

Rank Sector Weight
1 Healthcare 28.3%
2 Technology 21.95%
3 Financials 6.74%
4 Communication Services 5.79%
5 Industrials 5.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBRX icon
176
ImmunityBio
IBRX
$8.04B
$197K 0.09%
71,000
+42,500
+149% +$120K
MUI
177
DELISTED
BlackRock Municipal Income Fund, Inc.
MUI
$191K 0.08%
16,724
PMD
178
DELISTED
Psychemedics Corporation
PMD
$189K 0.08%
41,501
-3,000
-7% -$15.2K
DB icon
179
Deutsche Bank
DB
$67.3B
$176K 0.08%
16,700
NXJ
180
DELISTED
Nuveen New Jersey Quality Municipal Income Fund
NXJ
$173K 0.08%
15,106
FXN icon
181
First Trust Energy AlphaDEX Fund
FXN
$393M
$164K 0.07%
10,500
ETJ
182
Eaton Vance Risk-Managed Diversified Equity Income Fund
ETJ
$561M
$159K 0.07%
19,394
KEY icon
183
KeyCorp
KEY
$25.4B
$150K 0.07%
16,214
-1,000
-6% -$10.4K
LPCN icon
184
Lipocine
LPCN
$18.4M
$148K 0.06%
29,273
-15,237
-34% -$71.7K
HA
185
DELISTED
Hawaiian Holdings, Inc.
HA
$145K 0.06%
13,500
+1,000
+8% +$8.66K
ET icon
186
Energy Transfer Partners
ET
$69.9B
$131K 0.06%
10,300
FLG
187
Flagstar Bank National Association
FLG
$6.21B
$129K 0.06%
+3,833
New +$116K
AUTL
188
Autolus Therapeutics
AUTL
$383M
$112K 0.05%
47,000
+2,000
+4% +$4.75K
ONDS icon
189
Ondas Inc
ONDS
$3.72B
$94.6K 0.04%
109,900
+44,000
+67% +$41.9K
BFX
190
DELISTED
BowFlex Inc.
BFX
$93.2K 0.04%
76,408
-1,100
-1% -$1.4K
STXS icon
191
Stereotaxis
STXS
$154M
$91.1K 0.04%
59,560
ICCC icon
192
ImmuCell
ICCC
$101M
$80.6K 0.04%
16,117
+450
+3% +$2.3K
BCS icon
193
Barclays
BCS
$93.8B
$78.6K 0.03%
10,000
VVR icon
194
Invesco Senior Income Trust
VVR
$456M
$75.9K 0.03%
19,705
-7,900
-29% -$29.3K
CATX icon
195
Perspective Therapeutics
CATX
$341M
$73.5K 0.03%
11,000
BYRN icon
196
Byrna Technologies
BYRN
$75.8M
$50.1K 0.02%
+10,000
New +$54K
HYFM icon
197
Hydrofarm Holdings
HYFM
$3.25M
$47.6K 0.02%
6,090
+2,805
+85% +$33.5K
AMLI
198
DELISTED
American Lithium Corp. Common Stock
AMLI
$20.1K 0.01%
+10,000
New +$21K
AKBA icon
199
Akebia Therapeutics
AKBA
$359M
$16.8K 0.01%
18,316
HYZN
200
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
$14.4K 0.01%
300
+100
+50% +$3.66K

Similar funds

Wealth Effects's Q2 2023 Portfolio in Review

As of Q2 2023, Wealth Effects held 213 positions worth $227M, up 16% from $195M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Wealth Effects's Q2 2023 filing shows 15 new, 72 increased, 78 reduced and 11 closed positions. Its largest new stake was Meta Platforms (Facebook): 2,070 shares worth $594K. The largest sale was Avadel Pharmaceuticals, an estimated $1.69M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

  • Wealth Effects's largest Q2 2023 buy was Meta Platforms (Facebook): 2,070 shares worth $594K.
  • Wealth Effects added most to SentinelOne in Q2 2023, an estimated $696K increase.
  • Wealth Effects's biggest Q2 2023 reduction was Avadel Pharmaceuticals, cutting an estimated $1.69M.
  • Wealth Effects fully exited Twilio in Q2 2023, selling an estimated $465K.
  • Wealth Effects's ten largest holdings make up 46% of its $227M portfolio in Q2 2023.
  • Wealth Effects opened 15 new positions and closed 11 in Q2 2023.
  • Wealth Effects's portfolio value rose 16% quarter-over-quarter to $227M.

Based on Wealth Effects's 13F filing for Q2 2023, filed 18 Jul 2023.